Optical coherence tomography in the diagnosis of basal cell carcinoma

Archives of Dermatological Research

Volumn 307, Issue 1, 2015, Pages

  Hussain, Alia Arif ^a   Themstrup, Lotte ^a   Jemec, Gregor Borut Ernst ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Basal cell; carcinoma; Highdefinition; Non melanoma skin cancer; Optical coherence tomography; Skin cancer; Skin imaging

Indexed keywords

IMIQUIMOD;

BASAL CELL CARCINOMA; BIBLIOGRAPHIC DATABASE; CANCER DIAGNOSIS; CANCER PATIENT; CARCINOGENESIS; CONFOCAL MICROSCOPY; DERMIS; EN FACE OPTICAL COHERENCE TOMOGRAPHY; HAIR FOLLICLE; HIGH DEFINITION OPTICAL COHERENCE TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MEDLINE; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REFLECTANCE CONFOCAL MICROSCOPY; REFRACTION INDEX; REVIEW; SKIN DEFECT; SKIN TUMOR; SYSTEMATIC REVIEW; TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS;

CARCINOMA, BASAL CELL; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84943819229     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1498-y     Document Type: Review

References (46)

1. Alawi SA, Kuck M, Wahrlich C, Batz S, McKenzie G, Fluhr JW, Lademann J, Ulrich M (2013) Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer: a practical approach. Exp Dermatol 22(8):547-551. doi:10.1111/ exd.12196
2. Banzhaf CA, Themstrup L, Ring HC, Mogensen M, Jemec GBE (2014) Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin Res Technol 20(2):170-176. doi:10.1111/srt.12102
3. Bechara FG, Gambichler T, Stucker M, Orlikov A, Rotterdam S, Altmeyer P, Hoffmann K (2004) Histomorphologic correlation with routine histology and optical coherence tomography. Skin Res Technol 10(3):169-173. doi:10.1111/j.1600-0846.2004. 00038.x
4. Boone M, Jemec GB, Del Marmol V (2012) High-definition optical coherence tomography enables visualization of individual cells in healthy skin: comparison to reflectance confocal microscopy. Exp Dermatol 21(10):740-744. doi:10.1111/j.1600- 0625.2012.01569.x
5. Boone M, Norrenberg S, Jemec G, Del Marmol V (2013) Highdefinition optical coherence tomography: adapted algorithmic method for pattern analysis of inflammatory skin diseases: a pilot study. Arch Dermatol Res 305(4):283-297. doi:10.1007/s00403- 012-1311-8
6. Boone MA, Norrenberg S, Jemec GB, Del Marmol V (2012) Imaging of basal cell carcinoma by high-definition optical coherence tomography: histomorphological correlation. A pilot study. Br J Dermatol 167(4):856-864. doi:10.1111/j.1365-2133. 2012.11194.x
7. Boone MA, Norrenberg S, Jemec GB, Del Marmol V (2013) Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study. Exp Dermatol 22(2):93-97. doi:10.1111/exd.12074
8. Chan CS, Rohrer TE (2012) Optical coherence tomography and its role in Mohs micrographic surgery: a case report. Case Rep Dermatol 4(3):269-274. doi:10.1159/000346237
9. Coleman AJ, Richardson TJ, Orchard G, Uddin A, Choi MJ, Lacy KE (2013) Histological correlates of optical coherence tomography in non-melanoma skin cancer. Skin Res Technol 19(1):10-19. doi:10.1111/j.1600-0846.2012.00626.x
10. Cunha D, Richardson T, Sheth N, Orchard G, Coleman A, Mallipeddi R (2011) Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery. Br J Dermatol 165(3):576-580. doi:10.1111/j.1365-2133. 2011.10461.x
11. Dalimier E, Salomon D (2012) Full-field optical coherence tomography: a new technology for 3D high-resolution skin imaging. Dermatology 224(1):84-92
12. Durkin JR, Fine JL, Sam H, Pugliano-Mauro M, Ho J (2014) Imaging of Mohs micrographic surgery sections using full-field optical coherence tomography: a pilot study. Dermatol Surg 40(3):266-274. doi:10.1111/dsu.12419
13. Forsea AM, Carstea EM, Ghervase L, Giurcaneanu C, Pavelescu G (2010) Clinical application of optical coherence tomography for the imaging of non-melanocytic cutaneous tumors: a pilot multi-modal study. J Med Life 3(4):381-389
14. Gambichler T, Jaedicke V, Terras S (2011) Optical coherence tomography in dermatology: technical and clinical aspects. Arch Dermatol Res 303(7):457-473. doi:10.1007/s00403-011-1152-x
15. Gambichler T, Moussa G, Sand M, Sand D, Altmeyer P, Hoffmann K (2005) Applications of optical coherence tomography in dermatology. J Dermatol Sci 40(2):85-94. doi:10.1016/j. jdermsci.2005.07.006
16. Gambichler T, Orlikov A, Vasa R, Moussa G, Hoffmann K, Stucker M, Altmeyer P, Bechara FG (2007) In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci 45(3):167-173. doi:10.1016/j.jdermsci.2006.11.012
17. Gambichler T, Plura I, Kampilafkos P, Valavanis K, Sand M, Bechara FG, Stucker M (2014) Histopathological correlates of basal cell carcinoma in the slice and en face imaging modes of high-definition optical coherence tomography. Br J Dermatol 170(6):1358-1361. doi:10.1111/bjd.12797
18. Hinz T, Ehler LK, Hornung T, Voth H, Fortmeier I, Maier T, Holler T, Schmid-Wendtner MH (2012) Preoperative characterization of basal cell carcinoma comparing tumour thickness measurement by optical coherence tomography, 20-MHz ultrasound and histopathology. Acta Derm Venereol 92(2):132-137. doi:10.2340/00015555-1231
19. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178-1181
20. Jorgensen TM, Tycho A, Mogensen M, Bjerring P, Jemec GB (2008) Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography. Skin Res Technol 14(3):364-369. doi:10.1111/j. 1600-0846.2008.00304.x
21. Kamyab-Hesari K, Seirafi H, Naraghi ZS, Shahshahani MM, Rahbar Z, Damavandi MR, Naraghi MM, Rezvani M, Aghazadeh N (2014) Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol 28(2):250-253. doi:10.1111/j.1468-3083.2012.04695.x
22. Khandwala M, Penmetsa BR, Dey S, Schofield JB, Jones CA, Podoleanu A (2010) Imaging of periocular basal cell carcinoma using en face optical coherence tomography: a pilot study. Br J Ophthalmol 94(10):1332-1336. doi:10.1136/bjo.2009.170811
23. Maier T, Braun-Falco M, Hinz T, Schmid-Wendtner MH, Ruzicka T, Berking C (2013) Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol 27(1):e97-e104. doi:10.1111/j.1468-3083. 2012.04551.x
24. Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C (2013) Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol 168(1):120-128. doi:10.1111/j. 1365-2133.2012.11202.x
25. Marschall S, Sander B, Mogensen M, Jorgensen TM, Andersen PE (2011) Optical coherence tomography-current technology and applications in clinical and biomedical research. Anal Bioanal Chem 400(9):2699-2720. doi:10.1007/s00216-011-5008-1
26. Mogensen M, Jemec GB (2007) Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg 33(10):1158-1174. doi:10.1111/j.1524-4725. 2007.33251.x
27. Mogensen M, Joergensen TM, Nurnberg BM, Morsy HA, Thomsen JB, Thrane L, Jemec GB (2009) Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer- blinded evaluation by dermatologists and pathologists. Dermatol Surg 35(6):965-972. doi:10.1111/j.1524-4725.2009. 01164.x
28. Mogensen M, Jorgensen TM, Thrane L, Nurnberg BM, Jemec GB (2010) Improved quality of optical coherence tomography imaging of basal cell carcinomas using speckle reduction. Exp Dermatol 19(8):e293-e295. doi:10.1111/j.1600-0625.2009. 00979.x
29. Mogensen M, Nurnberg BM, Forman JL, Thomsen JB, Thrane L, Jemec GB (2009) In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound. Br J Dermatol 160(5):1026-1033. doi:10.1111/j.1365-2133.2008.09003.x
30. Mogensen M, Nurnberg BM, Thrane L, Jorgensen TM, Andersen PE, Jemec GB (2011) How histological features of basal cell carcinomas influence image quality in optical coherence tomography. J Biophotonics 4(7-8):544-551. doi:10.1002/jbio. 201100006
31. Mogensen M, Thrane L, Jorgensen TM, Andersen PE, Jemec GB (2009) OCT imaging of skin cancer and other dermatological diseases. J Biophotonics 2(6-7):442-451. doi:10.1002/jbio. 200910020
32. Olmedo JM, Warschaw KE, Schmitt JM, Swanson DL (2006) Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study. J Am Acad Dermatol 55(3):408-412. doi:10.1016/j.jaad.2006.03.013
33. Olmedo JM, Warschaw KE, Schmitt JM, Swanson DL (2007) Correlation of thickness of basal cell carcinoma by optical coherence tomography in vivo and routine histologic findings: a pilot study. Dermatol Surg 33(4):421-425. doi:10.1111/j.1524- 4725.2007.33088.x (discussion 425-426)
34. Pomerantz R, Zell D, McKenzie G, Siegel DM (2011) Optical coherence tomography used as a modality to delineate basal cell carcinoma prior to Mohs micrographic surgery. Case Rep Dermatol 3(3):212-218. doi:10.1159/000333000
35. Roozeboom MH, Mosterd K, Winnepenninckx VJ, Nelemans PJ, Kelleners-Smeets NW (2013) Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 27(7):894-898. doi:10.1111/j.1468-3083.2012.04608.x
36. Steiner R, Kunzi-Rapp K, Scharffetter-Kochanek K (2003) Optical coherence tomography: clinical applications in dermatology. Med Laser Appl 18(3):249-259. doi:10.1078/1615-1615- 00107
37. Swanson EA, Izatt JA, Hee MR, Huang D, Lin CP, Schuman JS, Puliafito CA, Fujimoto JG (1993) In vivo retinal imaging by optical coherence tomography. Opt Lett 18(21):1864-1866
38. Themstrup L, Banzhaf CA, Mogensen M, Jemec GB (2014) Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions. Photodiagnosis Photodyn Ther 11(1):7-12. doi:10.1016/j.pdpdt.2013.11.003
39. Tycho AAP, Thrane L, Jemec GBE (2006) Optical coherence tomography in dermatology. In: Serup J, Jemec GBE, Grove GL (eds) Handbook of Non-invasive methods and the Ski, 2nd edn. Taylor and Francis Group, Florida, pp 257-266
40. Ulrich M, Roewert-Huber J, Gonzalez S, Rius-Diaz F, Stockfleth E, Kanitakis J (2011) Peritumoral clefting in basal cell carcinoma: correlation of in vivo reflectance confocal microscopy and routine histology. J Cutan Pathol 38(2):190-195. doi:10.1111/j. 1600-0560.2010.01632.x
41. Wang KX, Meekings A, Fluhr JW, McKenzie G, Lee DA, Fisher J, Markowitz O, Siegel DM (2013) Optical coherence tomography- based optimization of Mohs micrographic surgery of Basal cell carcinoma: a pilot study. Dermatol Surg 39(4):627-633. doi:10.1111/dsu.12093
42. Welzel J (2001) Optical coherence tomography in dermatology: a review. Skin Res Technol 7(1):1-9
43. Wolberink EA, Pasch MC, Zeiler M, van Erp PE, Gerritsen MJ (2013) High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 27(8):985-989. doi:10.1111/j. 1468-3083.2012.04628.x
44. Ziolkowska M, Philipp CM, Liebscher J, Berlien H-P (2009) OCT of healthy skin, actinic skin and NMSC lesions. Med Laser Appl 24(4):256-264. doi:10.1016/j.mla.2009.07.003
45. Zulfakar MH, Alex A, Povazay B, Drexler W, Thomas CP, Porter RM, Heard CM (2011) In vivo response of GsdmA3Dfl/? mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining. Exp Dermatol 20(3):269-272. doi:10.1111/j.1600- 0625.2010.01233.x
46. Boone MA, Norrenberg S, Jemec GB, Del MV (2014) Highdefinition optical coherence tomography imaging of melanocytic lesions: a pilot study. Arch Dermatol Res 306:11-26